Literature DB >> 27497408

The impact of submandibular duct relocation on drooling and the well-being of children with neurodevelopmental disabilities.

Saskia E Kok1, Jan J W van der Burg2, Karen van Hulst3, Corrie E Erasmus4, Frank J A van den Hoogen5.   

Abstract

OBJECTIVE: The aim of this study was to evaluate the impact of a reduction in drooling after bilateral submandibular duct relocation (SMDR) with sublingual gland excision on daily life and care, as well as social and emotional consequences in children and adolescents with neurodevelopmental disabilities.
METHODS: This prospective cohort study included 72 children and adolescents (46 males, 26 females) with moderate to severe drooling, and their caregivers. Mean age at the time of surgery was 15 years 2 months (SD 4y 3mo). Fifty-two children were diagnosed with cerebral palsy and 20 had other non-progressive developmental disabilities. A caregiver questionnaire to document the impact of drooling on daily care and economic consequences, social interaction and emotional development and self-esteem was administered before, and 8 and 32 weeks after surgery.
RESULTS: Following bilateral SMDR the mean Visual Analogue Scale (VAS, 0-100) scores demonstrated a significant (p < 0.001) reduction in the severity of drooling from 81 at baseline to 28 and 36 after 8 and 32 weeks, respectively. This was accompanied by a decrease in the amount of daily care required and reduced economic consequences. In addition, an increase in social contact with other children and adults was reported by caregivers after surgery.
CONCLUSION: Bilateral SMDR with sublingual gland excision provides a significant positive reduction in daily care of children suffering from drooling. Caregivers also report positive changes in their child's social interaction and sense of self-esteem.
Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Children and adolescents; Quality of life; Sialorrhea; Submandibular duct rerouting

Mesh:

Year:  2016        PMID: 27497408     DOI: 10.1016/j.ijporl.2016.06.043

Source DB:  PubMed          Journal:  Int J Pediatr Otorhinolaryngol        ISSN: 0165-5876            Impact factor:   1.675


  6 in total

Review 1.  Hypersalivation: update of the German S2k guideline (AWMF) in short form.

Authors:  Armin Steffen; Wolfgang Jost; Tobias Bäumer; Dirk Beutner; Sabine Degenkolb-Weyers; Martin Groß; Maria Grosheva; Samer Hakim; Kai G Kahl; Rainer Laskawi; Rebekka Lencer; Jan Löhler; Thekla Meyners; Saskia Rohrbach-Volland; Rainer Schönweiler; Sara-Christina Schröder; Sebastian Schröder; Heidrun Schröter-Morasch; Maria Schuster; Susanne Steinlechner; Roland Urban; Orlando Guntinas-Lichius
Journal:  J Neural Transm (Vienna)       Date:  2019-04-10       Impact factor: 3.575

Review 2.  Surgical Management of the Drooling Child.

Authors:  Rachael Lawrence; Neil Bateman
Journal:  Curr Otorhinolaryngol Rep       Date:  2018-03-20

3.  Changes in severity and impact of drooling after submandibular gland botulinum neurotoxin A injections in children with neurodevelopmental disabilities.

Authors:  Karen Van Hulst; Jan Jw Van Der Burg; Peter H Jongerius; Alexander Ch Geurts; Corrie E Erasmus
Journal:  Dev Med Child Neurol       Date:  2019-11-14       Impact factor: 5.449

4.  Cost-effectiveness of botulinum neurotoxin A versus surgery for drooling: a randomized clinical trial.

Authors:  Stijn Bekkers; Kim J van Ulsen; Eddy M M Adang; Arthur R T Scheffer; Frank J A van den Hoogen
Journal:  Dev Med Child Neurol       Date:  2020-07-24       Impact factor: 5.449

Review 5.  Therapy of Sialorrhea with Botulinum Neurotoxin.

Authors:  Wolfgang H Jost; Tobias Bäumer; Rainer Laskawi; Jaroslaw Slawek; Björn Spittau; Armin Steffen; Martin Winterholler; Ganesh Bavikatte
Journal:  Neurol Ther       Date:  2019-09-21

6.  Surgery versus botulinum neurotoxin A to reduce drooling and improve daily life for children with neurodevelopmental disabilities: a randomized controlled trial.

Authors:  Stijn Bekkers; Ineke M J Pruijn; Jan J W van der Burg; Karen van Hulst; Saskia E Kok; Corinne P Delsing; Arthur R T Scheffer; Frank J A van den Hoogen
Journal:  Dev Med Child Neurol       Date:  2021-05-16       Impact factor: 5.449

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.